Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium- and chloride-dependent GABA transporter 1 (GAT1) is a membrane protein responsible for the reuptake of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the central nervous system. It mediates transport of GABA together with sodium (Na⁺) and chloride (Cl⁻) ions, removing GABA from the synaptic cleft by shuttling it into presynaptic neurons or astrocytes. This process is essential for terminating synaptic transmission and recycling neurotransmitter. Disruption or dysfunction in SLC6A1/GAT1 activity has been implicated in neurological disorders such as epilepsy.
Inhibition of GABA reuptake
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium- and chloride-dependent GABA transporter 1 (GAT1).